HCC
Melittin inhibits tumor cell metastasis by reducing cell motility and migration via the suppression of Rac1-dependent pathway, suggesting that melittin is a potential therapeutic agent for HCC.
Melittin inhibits tumor cell metastasis by reducing cell motility and migration via the suppression of <span class="gene" id="18506888-8-103-107">Rac1</span>-dependent pathway, suggesting that melittin is a potential therapeutic agent for <span class="disease" id="18506888-8-189-192">HCC</span>.